Wonder pill
Merck & Co. said Tuesday that anacetrapib, its new type of cholesterol drug, cut heart attacks, deaths and other complications of heart disease in a huge, late-stage company-funded study of 30,000 people.
Merck & Co. said Tuesday that anacetrapib, its new type of cholesterol drug, cut heart attacks, deaths and other complications of heart disease in a huge, late-stage company-funded study of 30,000 people.